Efficacy and Safety of the Reduced Bivalirudin in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention Stratified by Renal Function (REDUCE BOLUS): A Single-Blind, Stratified Randomized, Non-inferiority Trial.

Hu, Qiang; Han, Ya-Ling; Zhou, Tie-Nan; Wang, Xiao-Zeng; Zhang, Quan-Yu

Hu, Qiang; Han, Ya-Ling; Zhou, Tie-Nan; Wang, Xiao-Zeng; Zhang, Quan-Yu.

Afiliação

Hu Q; Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
Han YL; Department of Cardiology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Zhou TN; Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
Wang XZ; Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
Zhang QY; Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.

Front Cardiovasc Med ; 9: 864048, 2022.

Article em En | MEDLINE | ID: mdl-35548446

Palavras-chave

activated clotting time; bivalirudin; bleeding; loading dose; percutaneous coronary intervention

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google